PDS Biotechnology Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +6,212.6% | -98.2% | 0.0% | +0.0% | +177.1% | -63.9% | +0.0% | +177.1% | +0.0% | – | |
| – | -34.7% | +20.3% | +10.2% | -1.0% | -7.5% | -23.7% | -64.3% | +178.2% | -7.1% | -0.1% | +197,267.8% | – | |
| – | -71.1% | -411.8% | – | – | -456.3% | – | – | – | +27.2% | -23.1% | +113.0% | – | |
| – | – | -75.0% | +2,899,800.0% | -100.0% | +0.0% | -100.0% | – | -100.0% | – | -20.0% | +0.0% | – | |
| – | – | – | – | -100.0% | +2,897,099,900.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | +22,157.6% | +0.0% | -85.2% | +118.5% | +189.8% | -48.6% | +853.2% | – | |
| – | +1,241.9% | +85.9% | -100.1% | – | +903.6% | +4,137.4% | -86.4% | -75.8% | +1,647.9% | -116.1% | +1,852.2% | – | |
| – | – | +336.3% | -188.4% | – | – | – | – | – | – | -1,084.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.